Article Text

Download PDFPDF

598 Recurrence and survival after laparoscopy versus laparotomy in early stage endometrial cancer: follow-up five years after a randomised trial
  1. Bianca Reijntjes1,
  2. Geertruida H De Bock1,
  3. Mieke Van Suijlichem1,
  4. Arjan A Kraaijenbrink2,
  5. Lasse Paulsen3,
  6. Nathalie Reesink-Peters4,
  7. Jorien Woolderink5,
  8. Marlies Bongers6,
  9. Mirjam Apperloo7 and
  10. Marian JE Mourits1
  1. 1University Medical Center Groningen; University of Groningen; Gynaecologic Oncology
  2. 2Rijnstate Ziekenhuis; Gynaecology
  3. 3Wilhelmina Hospital Assen; Gynaecology
  4. 4Medical Spectrum Twente Enschede; Gynaecology
  5. 5Martini Hospital Groningen; Gynaecology
  6. 6Maxima Medical Centre Veldhoven; Gynaecology
  7. 7Medical Centre Leeuwarden; Gynaecology


Introduction/Background Laparoscopic hysterectomy has been proven to be a safe surgical procedure and is globally accepted as the standard treatment for early-stage endometrial cancer, despite insufficient data on long-term survival. Aim was to provide the five-years outcomes of a randomised Dutch trial on total laparoscopic hysterectomy (TLH) versus total abdominal hysterectomy (TAH) in early-stage low-risk endometrial cancer.

Methodology Follow-up of a multi-centre, randomised controlled trial on TLH versus TAH without routine lymphadenectomy. A total of 279 women with stage I endometrial cancer were enrolled between 2007–2009 in a 2:1 randomisation to undergo either TLH (n=185) or TAH (n=94). Primary outcome was disease-free survival. Secondary outcomes were primary site of recurrence, overall and disease-specific survival. The Kaplan-Meier survival curves and Cox proportional hazard ratios were applied.

Results Follow-up data of 253/279 patients are available. At a median follow-up time of 5.0 years, disease-free survival was 90.4% after TLH and 83.3% after TAH, HR 0.68 (95% CI 0.31–1.49). There were no port-site metastases and local recurrence rates were comparable. After adjustment for the covariates, overall survival outcomes were comparable between groups HR 0.64 (95% CI 0.33–1.26). Disease-specific survival was comparable between both groups.

Conclusion This is the first study reporting on survival among women with early-stage endometrial cancer randomised to TLH or TAH, without routine lymphadenectomy. No significant differences were found in disease-free, overall and disease-specific survival five-years postoperatively. This supports the widespread use of laparoscopic hysterectomy as primary treatment procedure for early-stage, low-grade endometrial cancer.

Disclosures None.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.